[HTML][HTML] Cerebrospinal fluid metabolomics identifies 19 brain-related phenotype associations
The study of metabolomics and disease has enabled the discovery of new risk factors,
diagnostic markers, and drug targets. For neurological and psychiatric phenotypes, the …
diagnostic markers, and drug targets. For neurological and psychiatric phenotypes, the …
Reversal of established traumatic brain injury-induced, anxiety-like behavior in rats after delayed, post-injury neuroimmune suppression
KM Rodgers, YK Deming, FM Bercum… - Journal of …, 2014 - liebertpub.com
Traumatic brain injury (TBI) increases the risk of neuropsychiatric disorders, particularly
anxiety disorders. Yet, there are presently no therapeutic interventions to prevent the …
anxiety disorders. Yet, there are presently no therapeutic interventions to prevent the …
Liver-specific polygenic risk score is associated with Alzheimer's disease diagnosis
Background: Our understanding of the pathophysiology underlying Alzheimer’s disease (AD)
has benefited from genomic analyses, including those that leverage polygenic risk score (…
has benefited from genomic analyses, including those that leverage polygenic risk score (…
Large‐scale proteome and metabolome analysis of CSF implicates altered glucose and carbon metabolism and succinylcarnitine in Alzheimer's disease
INTRODUCTION A hallmark of Alzheimer's disease (AD) is the aggregation of proteins (amyloid
beta [A] and hyperphosphorylated tau [T]) in the brain, making cerebrospinal fluid (CSF) …
beta [A] and hyperphosphorylated tau [T]) in the brain, making cerebrospinal fluid (CSF) …
Cerebrospinal Fluid Sphingomyelins in Alzheimer's Disease, Neurodegeneration, and Neuroinflammation 1
Background: Sphingomyelin (SM) levels have been associated with Alzheimer’s disease (AD),
but the association direction has been inconsistent and research on cerebrospinal fluid (…
but the association direction has been inconsistent and research on cerebrospinal fluid (…
Liver-specific polygenic risk score is more strongly associated than genome-wide score with Alzheimer's disease diagnosis in a case-control analysis
Although our understanding of Alzheimer’s disease (AD) has greatly improved in recent years,
the root cause remains unclear, making it difficult to find effective diagnosis and treatment …
the root cause remains unclear, making it difficult to find effective diagnosis and treatment …
Neuropathology‐based APOE genetic risk score better quantifies Alzheimer's risk
INTRODUCTION Apolipoprotein E (APOE) ε4‐carrier status or ε4 allele count are included in
analyses to account for the APOE genetic effect on Alzheimer's disease (AD); however, this …
analyses to account for the APOE genetic effect on Alzheimer's disease (AD); however, this …
Post-GWAS multiomic functional investigation of the TNIP1 locus in Alzheimer's disease implicates mediation through GPX3
The recently reported TNIP1/GPX3 locus from AD GWAS studies was investigated. Using
proteomics and other functional omics data, we identified evidence for a functional mechanism …
proteomics and other functional omics data, we identified evidence for a functional mechanism …
Effect of pathway-specific polygenic risk scores for Alzheimer's disease (AD) on rate of change in cognitive function and AD-related biomarkers among asymptomatic …
Background: Genetic scores for late-onset Alzheimer’s disease (LOAD) have been associated
with preclinical cognitive decline and biomarker variations. Compared with an overall …
with preclinical cognitive decline and biomarker variations. Compared with an overall …
Large-scale proteome and metabolome analysis of CSF implicates altered glucose metabolism and succinylcarnitine in Alzheimer's disease
A major hallmark of Alzheimer’s disease (AD) is the aggregation of misfolded proteins (β-amyloid
(A) and hyperphosphorylated tau (T)) in the brain. As these proteins can be monitored …
(A) and hyperphosphorylated tau (T)) in the brain. As these proteins can be monitored …
